484 studies found for:    Open Studies | "Pancreatic Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Gemcitabine and CT-011 for Resected Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Cancer of the Pancreas;   Neoplasms Pancreatic;   Pancreatic Cancer;   Pancreas Cancer
Interventions: Biological: CT-011;   Drug: Gemcitabine
2 Recruiting Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
Conditions: Pancreas Cancer;   Localized Pancreas Cancer;   Non-metastatic Pancreas Cancer
Intervention: Drug: FOLFIRINOX Regimen
3 Recruiting Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Interventions: Drug: Gemcitabine and cisplatin;   Drug: Gemcitabine / Cisplatin
4 Recruiting Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer
Conditions: Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreas Neoplasms
Interventions: Drug: Modified FOLFIRINOX;   Radiation: Stereotactic Body Radiotherapy (SBRT)
5 Recruiting PANFIRE - Pilot-study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma
Conditions: Locally Advanced Pancreatic Carcinoma (LAPC);   Non-metastasized Unresectable Pancreatic Carcinoma;   Pancreatic Cancer
Intervention: Device: NanoKnife "Irreversible electroporation (IRE)"
6 Recruiting Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas
Conditions: Pancreatic Cyst;   Pancreatic Neoplasms;   Pancreatic Adenoma;   Pancreatic Cancer;   Pancreatic Islet Cell Tumors;   Lymph Node;   Lymphadenopathy
Interventions: Procedure: EUS-FNA;   Device: nCLE
7 Recruiting Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Conditions: Pancreatic Cyst;   Pancreatic Neoplasms;   Pancreatic Adenoma;   Pancreatic Cancer;   Pancreatic Islet Cell Tumors;   Lymph Node;   Lymphadenopathy;   GIST
Intervention: Device: EUS-FNA: Endoscopic ultrasound fine needle aspiration: ultrasound endoscopy of a lesion with aspiration of the lesion fluid through a needle
8 Recruiting Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Dietary Supplement: Ketogenic diet
9 Recruiting The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer;   Peutz-Jeghers Syndrome;   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
Intervention: Drug: Human synthetic secretin
10 Recruiting Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreatic Carcinoma Non-resectable;   Locally Advanced Malignant Neoplasm
Interventions: Drug: FOLFIRINOX;   Biological: Algenpantucel-L Immunotherapy;   Radiation: 5-FU Chemoradiation;   Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Nab-Paclitaxel
11 Unknown  Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Condition: Pancreatic Neoplasms
Interventions: Device: Heckel Infrared Radiant Heat Device;   Other: cisplatin, gemcitabine, interferon-alpha;   Other: thermochemotherapy
12 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
13 Recruiting Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
Condition: Pancreas Cancer
Interventions: Drug: gemcitabine;   Drug: 5-fluorouracil
14 Recruiting Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
Condition: Pancreatic Tumor
Intervention: Procedure: suspected pancreatic tumor
15 Recruiting DCE MRI in Diagnosing Patients With Pancreatic Cancer
Conditions: Hereditary Pancreatic Cancer;   Intraductal Papillary Mucinous Neoplasm of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Procedure: dynamic contrast-enhanced magnetic resonance imaging
16 Not yet recruiting Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Radiation: neoadjuvant short course IMRT;   Radiation: IORT
17 Recruiting Tumor Registry Pancreatic Cancer
Condition: Pancreas Cancer
Intervention:
18 Unknown  Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
Conditions: Adenocarincoma of Pancreas;   Stage III Pancreatic Cancer;   Stage IVA Pancreatic Cancer;   Stage IVB Pancreatic Cancer
Interventions: Drug: paclitaxel;   Drug: oxaliplatin;   Drug: leucovorin;   Drug: 5-fluorouracil;   Drug: glutathione;   Drug: calcium and magnesium;   Procedure: Chemotherapy;   Procedure: Chemoprotection;   Procedure: Complementary and alternative therapy
19 Recruiting A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Vantictumab;   Drug: Nab-Paclitaxel;   Drug: Gemcitabine
20 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Drug: OMP-54F28, Nab-Paclitaxel and Gemcitabine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years